Intralesional interferon-alpha-2b for the treatment of Peyronie's disease-Reference-Cited by-同舟云学术

Intralesional interferon-alpha-2b for the treatment of Peyronie's disease

Published:2002-10 Issue:5 Volume:14 Page:336-339
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Lacy G L,Adams D M,Hellstrom W J G

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/3900867.pdf

Reference32 articles.

1. Carson CC . Francoix Gigot de la Peyronie Invest Urol 1981 19: 62–63

2. Levine LA . Peyronie's disease: a difficult sexual dysfunction problem West J Med 1998 169: 168–169

3. Gelbard MK, Dorey F, James K . The natural history of Peyronie's disease J Urol 1990 144: 1376–1379

4. Carson CC . Peyronie's disease: medical and surgical management In: Hellstrom WJG, ed Handbook of sexual dysfunction American Society of Andrology: San Francisco 1999 pp 93–98

5. Scardino PL, Scott WW . The use of tocopherols in the treatment of Peyronie's disease Ann NY Acad Sci 1949 52: 390–401

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intralesional drug therapy in dermatology;Indian Journal of Dermatology, Venereology, and Leprology;2017

2. Peyronie’s Disease: Intralesional Therapy and Surgical Intervention;Current Urology Reports;2016-07-18

3. A review of the epidemiology and treatment of Peyronie's disease;Research and Reports in Urology;2016-04

4. State of the art: medical treatment of Peyronie's disease;Expert Opinion on Orphan Drugs;2013-10-21

5. Systematic Evidence-Based Analysis of Plaque Injection Therapy for Peyronie's Disease;European Urology;2007-03